TB Natural History

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 9

Inhalation of aerosol droplets containing M.

tuberculosis with
subsequent deposition in the lungs leads to one of four possible
outcomes:
• Immediate clearance of the organism
• Primary disease: immediate onset of active disease
• Latent infection
• Reactivation disease: onset of active disease many years
following a period of latent infection
• About one fourth of the world’s population is estimated to be
infected with M. tuberculosis.

• Clinical illness directly following infection is classified as


primary TB and is common among children in the first few
years of life and among immunocompromised persons.

• When infection is acquired later in life, the chance is greater


that the mature immune system will contain it at least
temporarily.
• Bacilli, however, may persist for years before
reactivating to produce secondary (or postprimary) TB

• While the bacilli is in the lungs, macrophages produce


cytokines and chemokines that attract other phagocytic cells,
including monocytes, other alveolar macrophages, and
neutrophils, which eventually form a nodular granulomatous
structure called a tubercle.

• If the bacterial replication is not controlled, the tubercle


enlarges and the bacilli enter local draining lymph nodes,
leading to lymphadenopathy.
• The lesion (called Ghon focus) produced by the expansion of
the tubercle into the lung parenchyma and lymph node
enlargement or calcification together comprise the Ranke
complex.

• The bacilli continue to proliferate until an effective cell-


mediated immune (CMI) response develops, usually 2 to 10
weeks following initial infection; this occurs in more than 90
percent of exposed infected individuals.

• In the lung, failure of the host to mount an effective CMI


response and tissue repair leads to progressive destruction of
lung.
• Unchecked bacterial growth may lead to hematogenous
spread of bacilli to produce disseminated TB.

• Disseminated disease with lesions resembling millet seeds has


been termed miliary TB.

• Bacilli can also spread mechanically by erosion of the


caseating lesions into the airways; at this point, the host
becomes infectious to others.
• In the absence of treatment, death ensues in up to 80 percent
of cases.
Reactivation TB

• results from proliferation of a previously latent bacteria seeded at the


time of the primary infection.

• Upto 10% of infected persons will eventually develop active TB in


their lifetime—half of them during the first 18 months after
infection.

• The lifetime risk of reactivation disease after an index infection is 5


to 10 percent, with a 5 percent risk in the two to five years
following infection and another 5 percent risk over the remaining
lifetime.

• Among the approximately 5 to 10 percent of infected individuals


who develop active disease, approximately half will do so within
the first two to three years following infection.
• The risk is much higher among immunocompromised
individuals and, particularly, HIV-infected persons.

Immunosuppressive conditions associated with reactivation TB


include:
• HIV infection and AIDS
• Chronic and end-stage kidney disease
• Diabetes mellitus
• Lymphoma
• Corticosteroid use
• Inhibitors of TNF-alpha and its receptor
• Diminution in cell-mediated immunity associated with age
• Cigarette smoking
• The lesion typically occurs at the lung apices, and
disseminated disease is unusual unless the host is severely
immunosuppressed.

• Individuals with one episode of active TB have noted a two- to


fourfold increased risk of a second episode of active TB
compared with individuals without prior active disease
Untreated TB

• About one-third of patients died within 1 year after diagnosis.

• 55% of sputum smear-positive cases were dead within


5 years and up to 86% within 10 years.

• A lower case fatality rate, around 20%, was estimated for


untreated paucibacillary smear-negative cases at 5 years.

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy